Brought to you by 
Thermo Fisher in $15.2bn takeover of Life Technologies
10 Jun 2013
Executive Summary
After weeks of rumors, Thermo Fisher Scientific Inc. has finally publicly disclosed a definitive deal to acquire Life Technologies Corp. for $76 in cash per share (a 42% premium to the ten days prior to Life Tech’s announcement that it was conducting a strategic review), valuing the public life sciences company at $15.2bn, including $2.2bn in assumed net debt. The transaction is the largest M&A ever in the research field, surpassing Thermo Electron’s $11.8bn merger with Fisher Scientific in 2006.
Deal Industry
- Research, Analytical Equipment & Supplies
- Services
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com